Page last updated: 2024-10-26

ebselen and Candidiasis, Vulvovaginal

ebselen has been researched along with Candidiasis, Vulvovaginal in 3 studies

ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.

Candidiasis, Vulvovaginal: Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Liang, X1
Menon, S3
Vartak, R3
Gaida, R1
Wojaczyńska, E1
Patel, K3
Billack, B3
Patki, M1
Jablonski, J1
Mediouni, S1
Fu, Y1
Valente, ST1

Other Studies

3 other studies available for ebselen and Candidiasis, Vulvovaginal

ArticleYear
Nanoformulation of a novel potent ebselen analog for treatment of vulvovaginal candidiasis.
    Nanomedicine (London, England), 2023, Volume: 18, Issue:18

    Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Vulvovaginal; Female; Humans; Iso

2023
β-cyclodextrin polymer/Soluplus® encapsulated Ebselen ternary complex (EβpolySol) as a potential therapy for vaginal candidiasis and pre-exposure prophylactic for HIV.
    International journal of pharmaceutics, 2020, Nov-15, Volume: 589

    Topics: Antifungal Agents; Azoles; Candidiasis, Vulvovaginal; Cellulose; Cyclodextrins; Female; HeLa Cells;

2020
Evaluation of the antifungal activity of an ebselen-loaded nanoemulsion in a mouse model of vulvovaginal candidiasis.
    Nanomedicine : nanotechnology, biology, and medicine, 2021, Volume: 37

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Disease Models, Animal; Emu

2021